$CTGO
Contango ORE, Inc.

2020 Q2 Form 10-K Financial Statement

#000143774920020272 Filed on September 25, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.131M $1.272M $4.441M
YoY Change 67.47% -7.79% 17.86%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.131M $1.272M $4.441M
YoY Change 67.47% -7.79% 17.86%
Operating Profit
YoY Change
Interest Expense -$418.9K -$876.6K -$3.915M
YoY Change -52.21% -63.78% 61.71%
% of Operating Profit
Other Income/Expense, Net -$3.915M
YoY Change 61.71%
Pretax Income -$2.550M -$2.149M -$8.356M
YoY Change 18.65% -43.6% 35.02%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.550M -$2.149M -$8.356M
YoY Change 18.65% -43.6% 35.02%
Net Earnings / Revenue
Basic Earnings Per Share $1.33
Diluted Earnings Per Share -$389.0K -$338.1K -$1.330M
COMMON SHARES
Basic Shares Outstanding 6.557M 6.282M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.012M $8.601M $8.601M
YoY Change -64.98% -37.72% -37.73%
Cash & Equivalents $3.012M $8.601M
Short-Term Investments
Other Short-Term Assets $72.24K $161.2K $161.2K
YoY Change -55.19% 0.75% 3.55%
Inventory
Prepaid Expenses $72.24K $161.2K
Receivables
Other Receivables
Total Short-Term Assets $3.084M $8.762M $8.762M
YoY Change -64.8% -37.27% -37.27%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.084M $8.762M $8.762M
Total Long-Term Assets $0.00 $0.00
Total Assets $3.084M $8.762M $8.762M
YoY Change -64.8% -37.27% -37.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $83.16K $71.41K $71.41K
YoY Change 16.45% 538.05% 538.16%
Accrued Expenses $1.006M $347.9K $347.9K
YoY Change 189.25% 41.87% 41.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.089M $419.3K $419.3K
YoY Change 159.82% 63.53% 63.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.089M $419.3K $419.3K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.089M $419.3K $419.3K
YoY Change 159.82% 61.27% 63.53%
SHAREHOLDERS EQUITY
Retained Earnings -$58.90M -$49.66M
YoY Change 18.61% 20.23%
Common Stock $61.37M $58.00M
YoY Change 5.81% 5.43%
Preferred Stock
YoY Change
Treasury Stock (at cost) $476.7K
YoY Change
Treasury Stock Shares $32.87K $0.00
Shareholders Equity $1.995M $83.43M $8.343M
YoY Change
Total Liabilities & Shareholders Equity $3.084M $8.762M $8.762M
YoY Change -64.8% -37.27% -37.27%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019
OPERATING ACTIVITIES
Net Income -$2.550M -$2.149M -$8.356M
YoY Change 18.65% -43.6% 35.02%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$161.7K -$246.8K -$1.070M
YoY Change -34.47% -1.27% 6.9%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$420.0K -$930.0K -$4.140M
YoY Change -54.84% -63.95% 60.47%
Cash From Investing Activities -$420.0K -$930.0K -$4.140M
YoY Change -54.84% -63.95% 60.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -161.7K -246.8K -1.070M
Cash From Investing Activities -420.0K -930.0K -4.140M
Cash From Financing Activities 0.000 0.000
Net Change In Cash -581.7K -1.177M -5.210M
YoY Change -50.57% -58.42% -160.45%
FREE CASH FLOW
Cash From Operating Activities -$161.7K -$246.8K -$1.070M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
0
CY2019Q1 ctgo Contingent Salary And Compensation Retention Agreement
ContingentSalaryAndCompensationRetentionAgreement
1500000
CY2020Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
7143550
CY2019Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
6326503
CY2020Q2 ctgo Equity Method Investment Cumulative Investment
EquityMethodInvestmentCumulativeInvestment
11800000
ctgo Suspended Losses
SuspendedLosses
22900000
CY2020 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01 per share
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
83158
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
71410
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1006237
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
347879
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61302249
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
57935663
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2988331
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3368916
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3368916
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2988331
CY2020Q2 us-gaap Assets
Assets
3084162
CY2019Q2 us-gaap Assets
Assets
8761853
CY2020Q2 us-gaap Assets Current
AssetsCurrent
3084162
CY2019Q2 us-gaap Assets Current
AssetsCurrent
8761853
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2020 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">2.</div> Basis of Presentation</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America.</div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; color: rgb(0, 0, 0); text-indent: 27pt; font-size: 10pt; background-color: rgb(255, 255, 255);">These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. Since the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">'s primary business is now the investment in and management of the Joint Venture Company, it expects that its ongoing cash requirements will only be related to general and administration expenses and funding cash calls from the Joint Venture Company. The Company's sources of cash have historically been from common stock offerings.&nbsp; Given this, the Company believes that its current cash balances will be sufficient to meet its working capital requirements for the next <div style="display: inline; font-style: italic; font: inherit;">twelve</div> months from the date of this report.</div></div></div>
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3011918
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8600658
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8600658
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13810805
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3011918
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5588740
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5210147
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6590113
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6357113
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6557239
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6357113
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
65901
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
63571
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
5594995
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
4440546
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4054750
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3162174
CY2020Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
4370574
CY2019Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
3753579
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1161254
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1126078
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16730128
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14368334
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.43
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.43
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.33
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2019Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5594995
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4440546
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9240041
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8355839
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3720000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4140000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2361794
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2417453
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1940409
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1754726
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-6811
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
19523
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
202421
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-50715
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-616995
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-631535
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
670106
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
162885
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-88951
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1070147
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9240041
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-8355839
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5524
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
74954
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
224707
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3084162
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8761853
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1089395
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
419289
CY2020Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2019Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
0
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-476672
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3720000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4140000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1392068
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3645046
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3915293
CY2020Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
19100000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
476672
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
3368916
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2988331
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3720000
CY2019 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4140000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
72244
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
161195
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58896711
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49656670
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
13710072
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
8342564
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1994767
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
32874
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
476672
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
476672
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Management Estimates.</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;The preparation of consolidated financial statements in conformity with Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div>
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2400000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6475795
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6282285
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6475795
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6282285

Files In Submission

Name View Source Status
0001437749-20-020272-index-headers.html Edgar Link pending
0001437749-20-020272-index.html Edgar Link pending
0001437749-20-020272.txt Edgar Link pending
0001437749-20-020272-xbrl.zip Edgar Link pending
conta20200629_10k.htm Edgar Link pending
ctgo-20200630.xml Edgar Link completed
ctgo-20200630.xsd Edgar Link pending
ctgo-20200630_cal.xml Edgar Link unprocessable
ctgo-20200630_def.xml Edgar Link unprocessable
ctgo-20200630_lab.xml Edgar Link unprocessable
ctgo-20200630_pre.xml Edgar Link unprocessable
ex_203540.htm Edgar Link pending
ex_203541.htm Edgar Link pending
ex_203542.htm Edgar Link pending
ex_203543.htm Edgar Link pending
ex_203544.htm Edgar Link pending
ex_203545.htm Edgar Link pending
ex_203546.htm Edgar Link pending
ex_203547.htm Edgar Link pending
ex_203547img001.gif Edgar Link pending
ex_204994.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gradexthicknessmainpeakandno.jpg Edgar Link pending
image01.jpg Edgar Link pending
mapofhonaholes2019program-up.jpg Edgar Link pending
peakgenld092320.jpg Edgar Link pending
program-8oclock2oclockma.jpg Edgar Link pending
programeastpeakandnorths.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tet18-chiefdannydrill_areasc.jpg Edgar Link pending
tet18-copperhilldrill_areasc.jpg Edgar Link pending